Certification Rate
100%
Very high DOL cert
2026 data Public-data reference Official source
Aurobindo Pharma USA, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 22
- DOL-certified
- 100%
- Median offered wage
- $116,963
East Windsor, NJ NAICS: 424210
How many H-1B LCA filings list Aurobindo Pharma USA, Inc.?
U.S. Department of Labor's OFLC discloses 22 Labor Condition Application filings naming Aurobindo Pharma USA, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Aurobindo Pharma USA, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 93 H-1B petitions naming Aurobindo Pharma USA, Inc. through FY2023, and approved nearly every one of them: 97.8% approved (91 approvals, 2 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Aurobindo Pharma USA, Inc. is listed in 22 DOL LCA filings, more filings than 92% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $116,963. This is not a USCIS approval, hiring, or sponsorship ranking.
- 22
- DOL LCA filings, FY2023–FY2026
- 100%
- DOL-certified
- $116,963
- median offered wage
- Top 8%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in East Windsor, NJ.
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
Aurobindo Pharma USA, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
22 10522nd of 122824 higher than 112,302 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · Aurobindo Pharma USA, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $63,565–$290,000 .
Title concentration
- Financial and Investment Analyst 2 · 9.1% · $98,000
- EDI Analyst 2 · 9.1% · $105,950
- Vice President, Finance 1 · 4.5% · $180,066
- Software and AI Analyst 1 · 4.5% · $75,000
- Senior Vice President, Finance 1 · 4.5% · $233,126
Worksite counties
- MERCER, NJ 17 · 89.5%
- DURHAM, NC 2 · 10.5%
DOL LCA release change
What changed between the two LCA fiscal years
- Aurobindo Pharma USA, Inc.'s disclosed H-1B LCA filing count rose from 4 in FY2024 to 12 in FY2025 (+200%).
Above-prevailing wage posture
On 22 LCAs with comparable offered vs prevailing wages, Aurobindo Pharma USA, Inc. averages about 12.5% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Entry (Level I) (36.4% of LCA filings).
Growing filing trend
Completed-year LCA counts rose from 4 in FY2023 to 12 in FY2025 (≈3×). Cumulative volume: 22.
Mercer, NJ worksite concentration
Only 22 LCAs on file for Aurobindo Pharma USA, Inc., and 77.3% land in MERCER, NJ. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Avg. Salary
$116,963
Near portal avg
Total Workers
22
Small worker count
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at Aurobindo Pharma USA, Inc.
Minimum
$63,565
Maximum
$290,000
Average Salary
$116,963
Wage vs. DOL Minimum
+12.5%
At/above DOL floor
national avg +17.8%
Typical DOL Wage Level
Entry (Level I)
36.4% of LCA filings
Full-Time Positions
100%
Primary Worksite County
MERCER, NJ
77.3% of LCA filings
Top Occupations
Most frequently listed job titles at Aurobindo Pharma USA, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Financial and Investment Analyst | 2 | $98,000 |
| EDI Analyst | 2 | $105,950 |
| Vice President, Finance | 1 | $180,066 |
| Software and AI Analyst | 1 | $75,000 |
| Senior Vice President, Finance | 1 | $233,126 |
| Senior Scientist | 1 | $92,206 |
| Senior Analyst, Business Analytics | 1 | $110,007 |
| Senior Analyst, Analytical Lab | 1 | $80,000 |
| Regulatory Affairs Specialist | 1 | $64,355 |
| Manager, Supply Chain | 1 | $108,000 |
| Financial Analyst, IND-AS | 1 | $63,565 |
| Chief Financial Officer | 1 | $290,000 |
| Automation Engineer | 1 | $116,600 |
| Associate Director, Finance | 1 | $117,000 |
| Associate Director, Distribution Operations | 1 | $125,000 |
Nationwide peers near Aurobindo Pharma USA, Inc.'s 22-LCA band
Cross-state DOL neighbors for Aurobindo Pharma USA, Inc. - LCA filing-count and offered-wage axes, outside NJ.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (22 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($116,963 here).
Frequently Asked Questions
How many H-1B LCA filings list Aurobindo Pharma USA, Inc.?
Aurobindo Pharma USA, Inc. is listed in 22 DOL Labor Condition Application filings covering 22 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
How does Aurobindo Pharma USA, Inc.'s LCA filing volume compare to other employer filers?
Among 122,824 employer filers in the DOL disclosure extract, Aurobindo Pharma USA, Inc. ranks #10160 by total LCA filing count (22 filings). 112,302 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
What is the H-1B DOL certification rate for Aurobindo Pharma USA, Inc.?
Aurobindo Pharma USA, Inc. has a 100% DOL certification rate, with 22 out of 22 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
What offered wage is listed in LCAs for Aurobindo Pharma USA, Inc.?
The average offered wage listed in Aurobindo Pharma USA, Inc.'s LCAs is $116,963. Listed wages range from $63,565 to $290,000 and are not verified actual compensation.
What are the most common H-1B job titles at Aurobindo Pharma USA, Inc.?
The top job titles in Aurobindo Pharma USA, Inc.'s LCA filing records include Financial and Investment Analyst, EDI Analyst, Vice President, Finance. The most common listed title is Financial and Investment Analyst with 2 LCA filings at an average listed offered wage of $98,000. This does not establish actual job openings, hiring, or approved petitions.
Where is Aurobindo Pharma USA, Inc. located?
Aurobindo Pharma USA, Inc. is headquartered in East Windsor, NJ. Their H-1B workers are distributed across 3 states, with the most positions in NJ, NC, FL.
Is Aurobindo Pharma USA, Inc. H-1B dependent?
No, Aurobindo Pharma USA, Inc. is not classified as H-1B dependent.
How have Aurobindo Pharma USA, Inc.'s listed LCA filings changed over time?
Aurobindo Pharma USA, Inc. is listed in 4 LCA filings in FY2023 and 2 in FY2026. The average listed offered wage increased from $129,214 to $176,563. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
Read with Aurobindo Pharma USA, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PAR.
365 Retail Markets, LLC · MICRO-BOOK
ABS(total_petitions) peer at 22 LCAs (Δ 0 heavier vs Aurobindo Pharma USA, Inc.); CERT-SOLID · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
9Dots Technology, Inc · MICRO-BOOK
ABS(total_petitions) peer at 22 LCAs (Δ 0 heavier vs Aurobindo Pharma USA, Inc.); CERT-SOFT · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
AA Solutions Inc · MICRO-BOOK
ABS(total_petitions) peer at 22 LCAs (Δ 0 heavier vs Aurobindo Pharma USA, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
AAA United States, Inc. · MICRO-BOOK
ABS(total_petitions) peer at 22 LCAs (Δ 0 heavier vs Aurobindo Pharma USA, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PAR.
Ernst & Young US LLP · LARGEST-distance pole
NJ pole at 39,678 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Aurobindo Pharma USA, Inc.'s MICRO-BOOK.
NJ worksite board · MICRO-BOOK
Open the NJ state board after the ABS peers. Aurobindo Pharma USA, Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Wage levels primer · WAGE-PAR
Aurobindo Pharma USA, Inc.'s WAGE-PAR · MICRO-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.
What to do with this profile
Use the DOL LCA record for Aurobindo Pharma USA, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Aurobindo Pharma USA, Inc. filed 22 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 92% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in NJ rank on LCA filing volume this vintage. NJ filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.